Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT

v2.4.0.8
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT (USD $)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Stockholders' Equity - TransBiotec Inc.
Noncontrolling Interest
Total
Biginning Balance, Amount at Dec. 31, 2011 $ 254 $ 9,266,959 $ (10,720,938) $ (1,453,725) $ (34,880) $ (1,488,605)
Beginning Balance, Shares at Dec. 31, 2011 25,471,672          
Stock issued for cash, Shares 326,667          
Stock issued for cash, Amount 3 121,997    122,000    122,000
Share exchange - noncontrolling interest, Shares 251,105          
Share exchange - noncontrolling interest, Amount 3 (16,662)    (16,659) 16,659   
Stock issued for services, Shares 3,805,950          
Stock issued for services, Amount 38 2,321,919    2,321,957    2,321,957
Stock conversion of note payable , Shares 460,160          
Stock conversion of note payable, Amount 5 69,995    70,000    70,000
Paid in capital - beneficial conversion feature    39,929    39,929 207 40,136
Paid in capital - stock option expense    4,042    4,042    4,042
Paid in capital - Equity obligation settlement at fair value    95,100    95,100    95,100
Net Loss       (3,553,306) (3,553,306) (7,615) (3,560,921)
Ending Balance, Amount at Dec. 31, 2012 303 11,903,279 (14,274,244) (2,370,662) (25,629) (2,396,291)
Ending Balance, Shares at Dec. 31, 2012 30,315,554          
Share exchange - noncontrolling interest, Shares             
Share exchange - noncontrolling interest, Amount             (4,791) (4,791)
Stock issued for services, Shares 833,333          
Stock issued for services, Amount 9 77,424    77,433    77,433
Stock conversion of note payable , Shares 2,997,825          
Stock conversion of note payable, Amount 30 48,970    49,000    49,000
Paid in capital - beneficial conversion feature    76,951    76,951    76,951
Paid in capital - stock option expense    145,997    145,997    145,997
Paid in capital - Equity obligation settlement at fair value    163,018    163,018    163,018
Net Loss       (758,416) (758,416)    (758,416)
Ending Balance, Amount at Dec. 31, 2013 $ 342 $ 12,415,639 $ (15,032,660) $ (2,616,679) $ (30,420) $ (2,647,099)
Ending Balance, Shares at Dec. 31, 2013 34,146,712